12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease
Clinical trial NCT07034222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07034222
- Sponsor
- Ruijin Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-01-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.